ArticleCell death & disease2024

Targeting EMT using low-dose Teniposide by downregulating ZEB2-driven activation of RNA polymerase I in breast cancer.

Brandon J Metge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.